Prathap Nagaraja Shastri
Scientific Director and Group Leader, Clinical Pharmacology and Pharmacometrics Johnson & Johnson
Seminars
Wednesday 19th November 2025
speakers
9:45 am
Thursday 20th November 2025
Re-thinking Maximum Tolerated Dose (MTD) Using MIDD to Get the Dose Right First Time & Save Critical Development Time
9:00 am
- Learning how oncology modeling is evolving to prioritize optimal over maximum dosing
- Learn when is best to initiate dose optimization efforts
- Understand why MTD is being reconsidered
